2.71
前日終値:
$3.01
開ける:
$3.19
24時間の取引高:
159.43K
Relative Volume:
5.25
時価総額:
$1.01M
収益:
$11.51M
当期純損益:
$-54.00M
株価収益率:
-0.00381
EPS:
-711.8194
ネットキャッシュフロー:
$-23.73M
1週間 パフォーマンス:
-65.46%
1か月 パフォーマンス:
-81.05%
6か月 パフォーマンス:
-94.97%
1年 パフォーマンス:
-99.22%
Jaguar Health Inc Stock (JAGX) Company Profile
名前
Jaguar Health Inc
セクター
電話
415-371-8300
住所
200 PINE STREET SUITE 400, SAN FRANCISCO, CA
Compare JAGX vs VRTX, REGN, ARGX, ALNY, ONC
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
|
JAGX
Jaguar Health Inc
|
2.71 | 1.12M | 11.51M | -54.00M | -23.73M | -711.82 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.64 | 107.87B | 12.32B | 4.34B | 3.19B | 16.86 |
|
REGN
Regeneron Pharmaceuticals Inc
|
722.92 | 73.63B | 14.92B | 4.42B | 3.79B | 41.04 |
|
ARGX
Argen X Se Adr
|
808.25 | 49.42B | 4.16B | 1.29B | 734.26M | 19.58 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
302.37 | 40.20B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
312.83 | 33.06B | 5.36B | 287.73M | 924.18M | 2.5229 |
Jaguar Health Inc Stock (JAGX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2021-07-07 | 開始されました | Cantor Fitzgerald | Overweight |
| 2017-07-11 | 開始されました | Rodman & Renshaw | Buy |
Jaguar Health Inc (JAGX) 最新ニュース
Drug for lethal ultrarare childhood disease enters FDA breakthrough talks - Stock Titan
Jaguar Health Announces Preliminary Discussion with FDA to Evaluate Breakthrough Therapy Designation for Crofelemer for Treatment of Microvillus Inclusion Disease (MVID) - Yahoo Finance
Jaguar Health, Inc. Files Form 8-K with SEC – Company Information and Event Disclosure (May 2026) - Minichart
Jaguar Health Boosts Public Float to Regain Nasdaq Compliance - TipRanks
Jaguar Health | 8-K: Current report - Moomoo
Jaguar Health (NASDAQ: JAGX) lifts public float above Nasdaq minimum after split - Stock Titan
symbol__ Stock Quote Price and Forecast - CNN
Jaguar Health, Inc. Trade Ideas — GETTEX:1JA1 - TradingView
Jaguar Health, Inc. Files Form 8-K With SEC for May 2026 – Company Information, Nasdaq Listing, and Compliance Update - Minichart
Jaguar Health (JAGX) Set to Launch Neonorm Dog for Pet Wellness - GuruFocus
Jaguar Health to launch Neonorm Dog digestive health product By Investing.com - Investing.com Australia
Jaguar Health to launch Neonorm Dog digestive health product - Investing.com
Jaguar pushes Neonorm into dogs with plant-based, nonprescription gut aid - Stock Titan
Jaguar Animal Health Faces New Nasdaq Compliance Deficiency - TipRanks
Jaguar Health Expands Neonorm Franchise with Introduction of Neonorm Dog for Companion Animal Gut Health - ACCESS Newswire
Jaguar Health Disclosed Failure to Satisfy a Continued Listing Rule or Standard - TradingView
Jaguar Health (NASDAQ: JAGX) risks delisting after reverse split cuts public float - Stock Titan
MSN Money - MSN
Jaguar Health, Inc. Revenue Breakdown – MUN:1JA1 - TradingView
Working capital per share of Jaguar Health, Inc. – MUN:1JA1 - TradingView
Cash from investing activities of Jaguar Health, Inc. – MUN:1JA1 - TradingView
Jaguar Health, Inc. Cash Flow – MUN:1JA1 - TradingView
EBITDA of Jaguar Health, Inc. – MUN:1JA1 - TradingView
Jaguar Health, Inc. Income Statement – MUN:1JA1 - TradingView
Inventory turnover of Jaguar Health, Inc. – MUN:1JA1 - TradingView
Cost of goods sold of Jaguar Health, Inc. – MUN:1JA1 - TradingView
Return on equity % of Jaguar Health, Inc. – MUN:1JA1 - TradingView
Long term debt to total equity ratio of Jaguar Health, Inc. – MUN:1JA1 - TradingView
Total liabilities & shareholders' equities of Jaguar Health, Inc. – MUN:1JA1 - TradingView
Total liabilities of Jaguar Health, Inc. – FWB:1JA1 - TradingView
Net debt of Jaguar Health, Inc. – FWB:1JA1 - TradingView
Cash from financing activities of Jaguar Health, Inc. – FWB:1JA1 - TradingView
Tangible book value per share of Jaguar Health, Inc. – FWB:1JA1 - TradingView
Jaguar Health, Inc. Dividends – FWB:1JA1 - TradingView
Price to cash flow ratio of Jaguar Health, Inc. – FWB:1JA1 - TradingView
Jaguar Health, Inc. Earnings and Revenue – FWB:1JA1 - TradingView
Enterprise value to EBITDA ratio of Jaguar Health, Inc. – FWB:1JA1 - TradingView
Quick ratio of Jaguar Health, Inc. – FWB:1JA1 - TradingView
Total debt of Jaguar Health, Inc. – FWB:1JA1 - TradingView
Enterprise value of Jaguar Health, Inc. – FWB:1JA1 - TradingView
Total liabilities & shareholders' equities of Jaguar Health, Inc. – FWB:1JA1 - TradingView
Inventory turnover of Jaguar Health, Inc. – FWB:1JA1 - TradingView
Debt to assets ratio of Jaguar Health, Inc. – FWB:1JA1 - TradingView
Free cash flow per share of Jaguar Health, Inc. – FWB:1JA1 - TradingView
Operating cash flow per share of Jaguar Health, Inc. – FWB:1JA1 - TradingView
CapEx per share of Jaguar Health, Inc. – FWB:1JA1 - TradingView
Book value per share of Jaguar Health, Inc. – FWB:1JA1 - TradingView
Net current asset value per share of Jaguar Health, Inc. – FWB:1JA1 - TradingView
Return on invested capital % of Jaguar Health, Inc. – FWB:1JA1 - TradingView
Cash from operating activities of Jaguar Health, Inc. – FWB:1JA1 - TradingView
Jaguar Health, Inc. Balance Sheet – FWB:1JA1 - TradingView
Jaguar Health Inc (JAGX) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):